Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: From a perspective of a practical world

Rheumatology International

Volumn 32, Issue 12, 2012, Pages 3881-3886

  Deng, Xiaoli ^a   Liu, Xiangyuan ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

ACL; Anti 2GP1 antibody; Lupus; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BRAIN; CHINESE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LUNG ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; ULTRASOUND; YOUDEN INDEX;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 84872270819     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2267-2     Document Type: Article

References (16)

1. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for deWnite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295-306
2. Galli M, Luciani D, Bertolini G et al (2003) Anti-beta2-glycoproteinI, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102(8):2717-2723
3. Reber G, de Moerloose P (2004) Anti-beta2-glycoprotein I antibodies-when and how should they be measured? Thromb Res 14:527-531
4. Marai I, Gilburd B, Blank M et al (2003) Anti-cardiolipin and anti-?2-glycoprotein I (?2GP-I) antibody assays as screening for anti-phospholipid syndrome. Human Antibodies 12:57-62
5. Christoph M, Denise F, Hugh H et al (2005) Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 106(13):4152-4158
6. Meroni PL, Peyvandi F, Foco L et al (2007) Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women. J Thromb Haemost 5(12):2421-2428
7. Marai I, Shechter M, Langevitz P et al (2008) Anti-cardiolipin antibodies and endothelial function in patients with coronary artery disease. Am J Cardiol 101(8):1094-1097
8. Arad A, Proulle V, Furie RA et al (2011) {beta}2 glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are suYcient to potentiate arterial thrombus formation in a mouse model. Blood Jan 18. [Epub ahead of print]
9. Lavalle-Graef A, Villegas-Acosta L, Lavalle C (2004) Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus. Arch Med Res 35(5):421-427
10. Amelia R, Teresa Del R, Manuela C et al (2011) Risk factors for a Wrst thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study. Ann Rheum Dis Feb 1. [Epub ahead of print]
11. Sarzi-Puttini P, Atzeni F, Carrabba M (2003) Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome. Minerva Med 94(2):63-70
12. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
13. Cervera R, Khamashta MA, Front J et al (1993) Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore) 72:113-124
14. Tarr T, Lakos G, Bhattoa HP et al (2007) Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: A 5-year follow-up. Clin Rev Allergy Immunol 32(2):131-137
15. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for deWnite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
16. Bahar AM, Kwak JY, Beer AE et al (1993) Antibodies to phospholipids and nuclear antigens in non-pregnant women with unexplained spontaneous recurrent abortions. J Reprod Immunol 24:213-222